Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
2 hedge funds and large institutions have $18.6K invested in Medigus Ltd. Series C Warrant in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
60% less funds holding
Funds holding: 5 → 2 (-3)
89% less capital invested
Capital invested by funds: $164K → $18.6K (-$145K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$203K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$12K |
| 3 |
SM
Skaana Management
Brooklyn,
New York
|
-$7K |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$339 |
MDGSW Hedge Fund Activity: Q4 2022 in Review
2 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q4 2022, worth a combined $18.6K — down 89% from $164K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MDGSW and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Armistice Capital, cutting an estimated $203K.
- 2 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q4 2022, down from 5 in Q3 2022.
- Funds reported $18.6K of Medigus Ltd. Series C Warrant stock for Q4 2022, down 89% quarter-over-quarter.
- 0 funds opened new Medigus Ltd. Series C Warrant positions in Q4 2022 and 3 closed out, a net change of -3 holders.
- The largest Medigus Ltd. Series C Warrant seller in Q4 2022 was Armistice Capital, an estimated $203K sold.
Based on aggregated 13F filings for Q4 2022.